Pembrolizumab in HNSCC With Residual Disease After Radiation
Clinical trial NCT02892201 · TERMINATED
Trial details
- NCT number
- NCT02892201
- Sponsor
- Yale University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-08
- Primary completion
- 2020-02-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.